Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 271702011000036118 | Mylanta Double Strength (aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 30 mg) chewable tablet, 100 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 327591000036110 | Mylanta Double Strength chewable tablet, 100, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mylanta Double Strength chewable tablet, 100, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Mylanta Double Strength chewable tablet, 100, blister pack | Is a | Mylanta Double Strength chewable tablet, 100 | true | Inferred relationship | Some | ||
| Mylanta Double Strength chewable tablet, 100, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Mylanta Double Strength chewable tablet, 100, blister pack | has TPUU | Mylanta Double Strength chewable tablet | true | Inferred relationship | Some | 1 | |
| Mylanta Double Strength chewable tablet, 100, blister pack | has TP | Mylanta Double Strength | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
REPLACED BY association reference set
Containered trade product pack reference set
FHIR